Wittenberg Investment Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-210,239
| Closed | -$3.11M | – | 85 |
|
|
2024
Q1 | $3.11M | Hold |
210,239
| – | – | 1.06% | 20 |
|
|
2023
Q4 | $2.82M | Buy |
210,239
+500
| +0.2% | +$6.32K | 0.98% | 24 |
|
|
2023
Q3 | $2.59M | Buy |
209,739
+4,745
| +2% | +$57.5K | 0.95% | 23 |
|
|
2023
Q2 | $2.52M | Buy |
204,994
+7,000
| +4% | +$87.5K | 0.91% | 27 |
|
|
2023
Q1 | $2.43M | Buy |
197,994
+6,800
| +4% | +$79.9K | 0.91% | 26 |
|
|
2022
Q4 | $2.19M | Buy |
191,194
+2,500
| +1% | +$20.6K | 0.89% | 26 |
|
|
2022
Q3 | $708K | Hold |
188,694
| – | – | 0.3% | 50 |
|
|
2022
Q2 | $1.12M | Hold |
188,694
| – | – | 0.47% | 43 |
|
|
2022
Q1 | $1.19M | Hold |
188,694
| – | – | 0.45% | 35 |
|
|
2021
Q4 | $738K | Hold |
188,694
| – | – | 0.27% | 46 |
|
|
2021
Q3 | $911K | Sell |
188,694
-600
| -0.3% | -$3.13K | 0.35% | 37 |
|
|
2021
Q2 | $1.21M | Buy |
189,294
+3,096
| +2% | +$20.4K | 0.49% | 31 |
|
|
2021
Q1 | $1.17M | Hold |
186,198
| – | – | 0.54% | 30 |
|
|
2020
Q4 | $1.28M | Hold |
186,198
| – | – | 0.63% | 28 |
|
|
2020
Q3 | $620K | Hold |
186,198
| – | – | 0.33% | 35 |
|
|
2020
Q2 | $620K | Hold |
186,198
| – | – | 0.35% | 38 |
|
|
2020
Q1 | $400K | Hold |
186,198
| – | – | 0.22% | 45 |
|
|
2019
Q4 | $587K | Buy |
186,198
+1,080
| +0.6% | +$4.33K | 0.23% | 50 |
|
|
2019
Q3 | $831K | Sell |
185,118
-58,570
| -24% | -$293K | 0.36% | 43 |
|
|
2019
Q2 | $1.16M | Sell |
243,688
-30,998
| -11% | -$147K | 0.5% | 38 |
|
|
2019
Q1 | $1.5M | Sell |
274,686
-8,070
| -3% | -$37.1K | 0.64% | 36 |
|
|
2018
Q4 | $859K | Sell |
282,756
-41,034
| -13% | -$142K | 0.4% | 40 |
|
|
2018
Q3 | $1.36M | Buy |
323,790
+1,271
| +0.4% | +$5.36K | 0.56% | 36 |
|
|
2018
Q2 | $1.25M | Buy |
322,519
+165,791
| +106% | +$1.1M | 0.53% | 36 |
|
|
2018
Q1 | $993K | Buy |
156,728
+50,204
| +47% | +$415K | 0.43% | 39 |
|
|
2017
Q4 | $859K | Buy |
106,524
+23,886
| +29% | +$223K | 0.37% | 39 |
|
|
2017
Q3 | $945K | Buy |
+82,638
| New | +$869K | 0.41% | 39 |
|
Other funds holding MACK
RA
JC
Wittenberg Investment Management's MACK Position: Q2 2024 in Review
Wittenberg Investment Management sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2024, closing a stake of 210,239 shares — an estimated $3.11M sold.
Wittenberg Investment Management first reported a position in MACK in Q3 2017 and held it in 27 quarters. The position peaked at $3.11M in Q1 2024. 12 funds tracked by Wall St. Rank hold MACK as of Q2 2024.
- Wittenberg Investment Management reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2024 after selling out during the quarter.
- Wittenberg Investment Management sold 210,239 Merrimack Pharmaceuticals, Inc. shares in Q2 2024, an estimated $3.11M.
- Wittenberg Investment Management first reported a position in Merrimack Pharmaceuticals, Inc. in Q3 2017 and held it in 27 quarters.
- Wittenberg Investment Management's Merrimack Pharmaceuticals, Inc. position peaked at $3.11M in Q1 2024.
- 12 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2024.
Based on Wittenberg Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.